Published papers

Kabata, Hiroki

41-55 items (total 55)

[Group 2 innate lymphoid cells (ILC2s)].

Author: Kabata H, Moro K, Koyasu S, Asano K
Publication Title: Volume 64(Issue 1) Start Page 46 - End Page 56 (Publication Date）2015/02）
ISSN: 0021-4884

PubMed

A keratan sulfate disaccharide prevents inflammation and the progression of emphysema in murine models.

Author: Gao C, Fujinawa R, Yoshida T, Ueno M, Ota F, Kizuka Y, Hirayama T, Korekane H, Kitazume S, Maeno T, Ohtsubo K, Yoshida K, Yamaguchi Y, Lepenies B, Aretz J, Rademacher C, Kabata H, Hegab AE, Seeberger PH, Betsuyaku T, Kida K, Taniguchi N
Publication Title: Volume 312(Issue 2) Start Page L268 - End Page L276 (Publication Date）2017/02）
ISSN: 1040-0605

DOI1

PubMed

A Phase II study of S-1 and irinotecan combination therapy in previously treated patients with advanced non-small cell lung cancer.

Author: Ikemura S, Naoki K, Yasuda H, Kawada I, Yoda S, Terai H, Sato T, Ishioka K, Arai D, Ohgino K, Kamata H, Miyata J, Kabata H, Betsuyaku T, Soejima K
Publication Title: Volume 45(Issue 4) Start Page 356 - End Page 61 (Publication Date）2015/04）
ISSN: 0368-2811

DOI1

PubMed

Bone morphogenetic protein receptor type 2 mutations, clinical phenotypes and outcomes of Japanese patients with sporadic or familial pulmonary hypertension.

Author: Kabata H, Satoh T, Kataoka M, Tamura Y, Ono T, Yamamoto M, Huqun, Hagiwara K, Fukuda K, Betsuyaku T, Asano K
Publication Title: Volume 18(Issue 7) Start Page 1076 - End Page 82 (Publication Date）2013/10）
ISSN: 1323-7799

DOI1

PubMed

Characteristics of severe asthma with fungal sensitization.

Author: Masaki K, Fukunaga K, Matsusaka M, Kabata H, Tanosaki T, Mochimaru T, Kamatani T, Ohtsuka K, Baba R, Ueda S, Suzuki Y, Sakamaki F, Oyamada Y, Inoue T, Oguma T, Sayama K, Koh H, Nakamura M, Umeda A, Kamei K, Izuhara K, Asano K, Betsuyaku T
Publication Title: Volume 119(Issue 3) Start Page 253 - End Page 257 (Publication Date）2017/09）
ISSN: 1081-1206

DOI1

PubMed

Determinants of Long-Term Persistence with Tiotropium Bromide for Chronic Obstructive Pulmonary Disease.

Author: Tanaka K, Kamiishi N, Miyata J, Kabata H, Masaki K, Ogura-Tomomatsu H, Tomomatsu K, Suzuki Y, Fukunaga K, Sayama K, Betsuyaku T, Asano K
Publication Title: Volume 12(Issue 3) Start Page 233 - End Page 9 (Publication Date）2015/06）
ISSN: 1541-2555

DOI1

PubMed

Dual role of interleukin-23 in epicutaneously-sensitized asthma in mice.

Author: Masaki K, Suzuki Y, Kagawa S, Kodama M, Kabata H, Miyata J, Tanaka K, Fukunaga K, Sayama K, Oguma T, Kimura T, Amagai M, Betsuyaku T, Asano K
Publication Title: Start Page 13 - End Page 22 (Publication Date）2014/05）
ISSN: 1323-8930

DOI1

PubMed

Group 2 innate lymphoid cells and asthma.

Author: Kabata H, Moro K, Koyasu S, Asano K
Publication Title: Volume 64(Issue 3) Start Page 227 - End Page 34 (Publication Date）2015/07）
ISSN: 1323-8930

DOI1

PubMed

Influence of the Number Multiple Disease-Modifying Factors in Japanese Patients with Severe Asthma

Author: Watanabe R., Baba R., Kamatani T., Kuwae M., Okuzumi S., Tanosaki T., Matsusaka M., Mochimaru T., Kabata H., Ueda S., Suzuki Y., Asano K., Fukunaga K.
Publication Title: (Publication Date）2019）
ISSN: 1073-449X

Interferon and IL-27 antagonize the function of group 2 innate lymphoid cells and type 2 innate immune responses.

Author: Moro K, Kabata H, Tanabe M, Koga S, Takeno N, Mochizuki M, Fukunaga K, Asano K, Betsuyaku T, Koyasu S
Publication Title: Volume 17(Issue 1) Start Page 76 - End Page 86 (Publication Date）2016/01）
ISSN: 1529-2908

DOI1

PubMed

Isolation and analysis of group 2 innate lymphoid cells in mice.

Author: Moro K, Ealey KN, Kabata H, Koyasu S
Publication Title: Volume 10(Issue 5) Start Page 792 - End Page 806 (Publication Date）2015/05）
ISSN: 1754-2189

DOI1

PubMed

Mechanisms to Suppress ILC2-induced Airway Inflammation.

Author: Kabata H, Moro K, Koyasu S, Fukunaga K, Asano K, Betsuyaku T
Publication Title: Start Page S95 (Publication Date）2016/03）
ISSN: 2329-6933

DOI1

PubMed

Phenotype of asthma related with high serum periostin levels.

Author: Matsusaka M, Kabata H, Fukunaga K, Suzuki Y, Masaki K, Mochimaru T, Sakamaki F, Oyamada Y, Inoue T, Oguma T, Sayama K, Koh H, Nakamura M, Umeda A, Ono J, Ohta S, Izuhara K, Asano K, Betsuyaku T
Publication Title: Volume 64(Issue 2) Start Page 175 - End Page 80 (Publication Date）2015/04）
ISSN: 1323-8930

DOI1

PubMed

The neuropeptide neuromedin U stimulates innate lymphoid cells and type 2 inflammation.

Author: Klose CSN, Mahlakõiv T, Moeller JB, Rankin LC, Flamar AL, Kabata H, Monticelli LA, Moriyama S, Putzel GG, Rakhilin N, Shen X, Kostenis E, König GM, Senda T, Carpenter D, Farber DL, Artis D
Publication Title: Volume 549(Issue 7671) Start Page 282 - End Page 286 (Publication Date）2017/09）
ISSN: 0028-0836

DOI1

PubMed

Thymic stromal lymphopoietin induces corticosteroid resistance in natural helper cells during airway inflammation.

Author: Kabata H, Moro K, Fukunaga K, Suzuki Y, Miyata J, Masaki K, Betsuyaku T, Koyasu S, Asano K
Publication Title: Start Page 2675 (Publication Date）2013）

DOI1

PubMed

Kabata, Hiroki Details